Clinical Trials

70 enrolled

Breast Neoplasms, Arthralgia

NCT07178665 2025-11-14

Pilot Trial of Preop Partial Radiation in Breast Cancer Patients

98 enrolled

Breast Neoplasms, Carcinoma, Intraductal, Noninfiltrating

NCT06491654 2025-06-11

Physiotherapy Program Impact on Breast Cancer-Related Lymphedema

21 enrolled

Breast Cancer Lymphedema, Breast Neoplasms, Lymphedema

NCT06121453 2025-05-22

Adherence Intervention in Patients With Metastatic Breast Cancer

35 enrolled

Breast Neoplasms

NCT04973930 2025-05-13

IPT

Phase 3 Suspended

20 enrolled

Breast Neoplasms, Depressive Disorder, Major

NCT06214793 2025-05-01

Taletrectinib in Previously Treated Metastatic CDH1-mutated Invasive Lobular Cancer (ILC)

Phase 2 Suspended

61 enrolled

Breast Neoplasms

NCT04151368 2025-01-31

RNSM

30 enrolled

Breast Diseases, Breast Neoplasms, Genetic Predisposition to Disease

NCT02037529 2024-08-20

Eribulin Mesylate or Paclitaxel as First- or Second-Line Therapy in Treating Patients With Recurrent Stage IIIC-IV Breast Cancer

Phase 3 Suspended

201 enrolled 19 charts

Breast Neoplasms

NCT04946864 2024-08-19

A Study to Investigate the Safety, Tolerability, of APG-2575 as a Single Agent or in Combination for Breast Cancer

Phase 1/2 Suspended

65 enrolled

Breast Neoplasms

NCT04120246 2024-07-10

Alpha-TEA and Trastuzumab for the Treatment of Refractory HER2+ Metastatic Breast Cancer

24 enrolled

Breast Neoplasms, Neoplasm Metastasis

NCT04714983 2024-04-09

DNX-2440 for Resectable Colorectal Liver Metastasis

BreastDermatologicGastrointestinalGenitourinarySarcoma

30 enrolled

Breast Neoplasms, Carcinoma, Renal Cell, Carcinoma, Squamous Cell, Melanoma, Sarcoma, Stomach Neoplasms, Colorectal Neoplasms, Gastrointestinal Stromal Tumors

NCT04650451 2023-04-20

Safety and Activity Study of HER2-Targeted Dual Switch CAR-T Cells (BPX-603) in Subjects With HER2-Positive Solid Tumors

220 enrolled

BreastGastrointestinal

Breast Neoplasms, Stomach Neoplasms

NCT04116281 2022-07-12

Short and Long Term Effects of a Physical Therapy Program After Breast Cancer Surgery

36 enrolled

Breast Neoplasms

NCT02897050 2022-04-20

Trial of Neoadjuvant Docetaxel ± Metronomic Capecitabine/CTX Followed by FEC in Women With Operable Triple Negative Breast Cancer

Phase 2 Suspended

170 enrolled

Breast Neoplasms

NCT04683120 2021-06-30

Real-time Diagnosis and Visualization of Tumor Margins in Excised Breast Specimens Using Zenith FLIM Diagnostics

100 enrolled

Margins of Excision, Breast Neoplasms, Neoplasms

NCT03845907 2020-04-06

Clinical Evaluation of Opto-Acoustic Image Quality With the Gen1B Duplex Probe in Breast Applications

4 enrolled

Breast Neoplasms

NCT01589861 2017-03-28

PIKHER2

Phase 1/2 Suspended

106 enrolled

Breast Neoplasms

NCT00673829 2016-06-17

Trial of 2nd Generation Anti-CEA Designer T Cells in Metastatic Breast Cancer

26 enrolled

Breast Neoplasms

NCT00002696 2013-08-02

Combination Chemotherapy in Treating Women With Stage III Breast Cancer

Phase 3 Suspended

Breast Neoplasms

NCT01122342 2010-05-13

Vaginal Testosterone Cream For Atrophic Vaginitis in Women Taking Aromatase Inhibitors for Breast Cancer.

Phase 1/2 Suspended

30 enrolled

Breast Neoplasms, Dyspareunia, Vaginitis

NCT00909558 2010-02-24

Safety and Effectiveness Study of Autologous Natural Killer and Natural Killer T Cells on Cancer